Related references
Note: Only part of the references are listed.The G0/G1 Switch Gene 2 Regulates Adipose Lipolysis through Association with Adipose Triglyceride Lipase
Xingyuan Yang et al.
CELL METABOLISM (2010)
被撤回的出版物: The Skp2 Promoter Integrates Signaling through the NF-κB, p53, and Akt/GSK3β Pathways to Regulate Autophagy and Apoptosis (Retracted article. See vol. 55, pg. 342, 2014)
Benjamin Barre et al.
MOLECULAR CELL (2010)
Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
Daniela Bonofiglio et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Guardian of corpulence: a hypothesis on p53 signaling in the fat cell
Merlijn Bazuine et al.
CLINICAL LIPIDOLOGY (2009)
The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function
Philip Hallenborg et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
De-Novo Identification of PPARγ/RXR Binding Sites and Direct Targets during Adipogenesis
Mohamed Sabry Hamza et al.
PLOS ONE (2009)
Fbxw7 in cell cycle exit and stem cell maintenance Insight from gene-targeted mice
Ichiro Onoyama et al.
CELL CYCLE (2008)
Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance
Noriyuki Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
p38MAP Kinase activity is required for human primary adipocyte differentiation
M. Aouadi et al.
FEBS LETTERS (2007)
P21WAF1/CIP1 is a common transcriptional target of retinoid receptors
Takemi Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
RAR and RXR modulation in cancer and metabolic disease
Lucia Altucci et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Skp2 controls adipocyte proliferation during the development of obesity
Tamon Sakai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome
Jane A. Pinaire et al.
PPAR RESEARCH (2007)
Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms
Tatsuo Okada et al.
DIABETES (2006)
The G0/G1 switch gene 2 is a novel PPAR target gene
F Zandbergen et al.
BIOCHEMICAL JOURNAL (2005)
p27Kip1 knockout mice are protected from diabetic nephropathy:: Evidence for p27Kip1 haplotype insufficiency
G Wolf et al.
KIDNEY INTERNATIONAL (2005)
Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome
AI Shulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
JH Mao et al.
NATURE (2004)
Erk 1,2 phosphorylates p27Kip1:: Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells
G Wolf et al.
DIABETOLOGIA (2003)
P53 activation in adipocytes of obese mice
N Yahagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of cell cycle proteins in glomerular disease
SV Griffin et al.
SEMINARS IN NEPHROLOGY (2003)
Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy
NA Wahab et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes
T Yamauchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes
T Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation
S Hauser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
